FDA's analysis of placebo-controlled clinical studies of eleven antiepileptic drugs showed patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation compared to patients receiving placebo.
January 31, 2008 | Filed Under News
Comments
FDA's analysis of placebo-controlled clinical studies of eleven antiepileptic drugs showed patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation compared to patients receiving placebo.
January 31, 2008 | Filed Under News
Comments
FDA's analysis of placebo-controlled clinical studies of eleven antiepileptic drugs showed patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation compared to patients receiving placebo.
January 31, 2008 | Filed Under News
Comments